Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Ur-Energy Inc. (URG)

Gold And Silver Ores

https://www.ur-energy.com

Ur-Energy Inc is y is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.

SUITE 200, 10758 W. CENTENNIAL ROAD
LITTLETON, CO

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/24/2008

Market Cap

387,633,180

Shares Outstanding

265,990,000

Weighted SO

265,989,118

Total Employees

N/A

Upcoming Earnings

08/05/2024

Beta

1.0980

Last Div

0.0000

Range

0.96-2.01

Chg

0.0100

Avg Vol

4228204

Mkt Cap

387633180

Exch

AMEX

Country

US

Phone

720 981 4588

DCF Diff

1.4242

DCF

-0.3642

Div Yield

0.0000

P/S

38.7578

EV Multiple

-7.3887

P/FV

3.3037

Div Yield %

0.0000

P/E

-6.4031

PEG

0.0875

Payout

-0.0168

Current Ratio

15.6741

Quick Ratio

14.5039

Cash Ratio

14.1407

DSO

8.5020

DIO

40.3613

Op Cycle

48.8633

DPO

24.0784

CCC

24.7849

Gross Margin

-3.5873

Op Margin

-4.6630

Pretax Margin

-4.7844

Net Margin

-4.7844

Eff Tax Rate

0.0162

ROA

-0.3404

ROE

-0.6032

ROCE

-0.3424

NI/EBT

1.0000

EBT/EBIT

1.0260

EBIT/Rev

-4.6630

Debt Ratio

0.0016

D/E

0.0024

LT Debt/Cap

0.0000

Total Debt/Cap

0.0024

Int Coverage

-58.4423

CF/Debt

-169.6544

Equity Multi

1.5155

Rec Turnover

42.9310

Pay Turnover

15.1588

Inv Turnover

9.0433

FA Turnover

0.1634

Asset Turnover

0.0712

OCF/Share

-0.1315

FCF/Share

-0.1410

Cash/Share

0.2141

OCF/Sales

-3.7652

FCF/OCF

1.0719

CF Coverage

-169.6544

ST Coverage

-169.6544

CapEx Coverage

-13.9102

Div&CapEx Cov

-10.7213

P/BV

3.3037

P/B

3.3037

P/S

38.7578

P/E

-6.4031

P/FCF

-9.6032

P/OCF

-8.1364

P/CF

-8.1364

PEG

0.0875

P/S

38.7578

EV Multiple

-7.3887

P/FV

3.3037

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jul 01, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 24, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 17, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 14, 11:48 IOVA SHAREHOLDERS: Iovance Biotherapeutics, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 14 Deadline (NASDAQ:IOVA) GlobeNewswire Inc. Jun 14, 11:48 URGN SHAREHOLDERS: UroGen Pharma Ltd. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 28 Deadline (NASDAQ:URGN) GlobeNewswire Inc. Jun 10, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UroGen, Strategy Incorporated, and Organon and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 06, 22:21 URGN Investors with Large Losses Should Contact Robbins LLP for Information About the Class Action Lawsuit Against UroGen Pharma Ltd. GlobeNewswire Inc. Jun 06, 21:48 UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA’s Briefing Document and Subsequent ODAC Vote Against UGN-102– Hagens Berman GlobeNewswire Inc. Jun 06, 00:00 Kirby McInerney LLP Reminds UroGen Pharma Ltd. (URGN) Investors of Class Action Filing and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 03, 01:00 UROGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against UroGen Pharma Ltd. and Encourages Investors to Contact the Firm GlobeNewswire Inc. May 29, 22:46 UroGen Pharma Ltd. Investors: Please contact the Portnoy Law Firm to recover your losses. July 28, 2025 Deadline to file Lead Plaintiff Motion. GlobeNewswire Inc. May 29, 22:44 Rocket Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm GlobeNewswire Inc. May 29, 22:39 Tempus AI, Inc. Investors: Company Investigated by the Portnoy Law Firm Benzinga May 16, 22:33 Securities Fraud Investigation Into UroGen Pharma Ltd. (URGN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz GlobeNewswire Inc. Jan 22, 18:00 SurgePays Announces Closing of $15 Million Public Offering GlobeNewswire Inc. Jan 22, 07:30 Surge Copper Intersects 548 metres grading 0.36% CuEq including 30 metres grading 0.61% CuEq at the Berg Deposit GlobeNewswire Inc. Jan 17, 20:01 SurgePays Announces Pricing of $15 Million Public Offering GlobeNewswire Inc. Jan 17, 20:01 SurgePays Announces Pricing of $15 Million Public Offering GlobeNewswire Inc. Jan 17, 20:01 SurgePays Announces Pricing of $15 Million Public Offering GlobeNewswire Inc. Jan 17, 20:01 SurgePays Announces Pricing of $15 Million Public Offering

Revenue Product Segmentation